Search

Shahid R. Merchant

Supervisory Patent Examiner (ID: 2793, Phone: (571)270-1360 , Office: P/3693 )

Most Active Art Unit
3694
Art Unit(s)
3694, 3626, 3692, 3684, 3693
Total Applications
227
Issued Applications
52
Pending Applications
22
Abandoned Applications
153

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17546634 [patent_doc_number] => 20220117975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF DEPRESSION AND OTHER DISORDERS [patent_app_type] => utility [patent_app_number] => 17/431422 [patent_app_country] => US [patent_app_date] => 2020-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37081 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431422 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/431422
Compositions and methods for treatment of depression and other disorders Feb 17, 2020 Issued
Array ( [id] => 17896974 [patent_doc_number] => 20220306636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-29 [patent_title] => PROCESS FOR PREPARING ENANTIOMERICALLY ENRICHED JAK INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/428850 [patent_app_country] => US [patent_app_date] => 2020-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28289 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428850 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/428850
Process for preparing enantiomerically enriched JAK inhibitors Feb 5, 2020 Issued
Array ( [id] => 17473918 [patent_doc_number] => 20220081422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => DIHYDROOROTATE DEHYDROGENASE INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/428997 [patent_app_country] => US [patent_app_date] => 2020-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39425 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -39 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428997 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/428997
DIHYDROOROTATE DEHYDROGENASE INHIBITORS Feb 5, 2020 Abandoned
Array ( [id] => 17561635 [patent_doc_number] => 20220125784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => METHODS AND COMPOUNDS FOR INHIBITION OF INACTIVATION OF VOLTAGE-GATED SODIUM CHANNELS [patent_app_type] => utility [patent_app_number] => 17/427949 [patent_app_country] => US [patent_app_date] => 2020-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13547 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427949 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/427949
METHODS AND COMPOUNDS FOR INHIBITION OF INACTIVATION OF VOLTAGE-GATED SODIUM CHANNELS Feb 3, 2020 Pending
Array ( [id] => 17577102 [patent_doc_number] => 20220133957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => Sclerostin Inhibitors That Promote Bone Morphogenetic Protein Expression [patent_app_type] => utility [patent_app_number] => 17/428556 [patent_app_country] => US [patent_app_date] => 2020-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12968 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428556 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/428556
Sclerostin Inhibitors That Promote Bone Morphogenetic Protein Expression Feb 3, 2020 Abandoned
Array ( [id] => 17503371 [patent_doc_number] => 20220096473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => METHOD FOR TREATING AN ACUTE MYELOID LEUKEMIA [patent_app_type] => utility [patent_app_number] => 17/421832 [patent_app_country] => US [patent_app_date] => 2020-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14925 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421832 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/421832
METHOD FOR TREATING AN ACUTE MYELOID LEUKEMIA Jan 14, 2020 Abandoned
Array ( [id] => 17503401 [patent_doc_number] => 20220096503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 17/422074 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11423 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422074 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/422074
COMBINATION PHARMACEUTICAL COMPOSITIONS AND METHODS THEREOF Jan 9, 2020 Pending
Array ( [id] => 17519234 [patent_doc_number] => 20220105082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 17/421867 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17421867 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/421867
NEW FORMULATIONS CONTAINING LEUKOTRIENE RECEPTOR ANTAGONISTS Jan 9, 2020 Abandoned
Array ( [id] => 17578722 [patent_doc_number] => 20220135577 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => DIHYDROPYRAZOLOPYRAZINONE DERIVATIVE HAVING MGAT2 INHIBITORY ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/422108 [patent_app_country] => US [patent_app_date] => 2020-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25912 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422108 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/422108
Dihydropyrazolopyrazinone derivative having MGAT2 inhibitory activity Jan 9, 2020 Issued
Array ( [id] => 17441774 [patent_doc_number] => 20220062279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => TREATMENT OF MOVEMENT DISORDERS [patent_app_type] => utility [patent_app_number] => 17/415236 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9976 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17415236 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/415236
TREATMENT OF MOVEMENT DISORDERS Dec 19, 2019 Abandoned
Array ( [id] => 17368142 [patent_doc_number] => 20220023194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => Cosmetic Mask Comprising a Plant Paper and Humectant [patent_app_type] => utility [patent_app_number] => 17/296693 [patent_app_country] => US [patent_app_date] => 2019-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5642 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296693 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/296693
Cosmetic Mask Comprising a Plant Paper and Humectant Nov 25, 2019 Pending
Array ( [id] => 18194386 [patent_doc_number] => 20230047905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-16 [patent_title] => COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/294965 [patent_app_country] => US [patent_app_date] => 2019-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -351 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294965 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/294965
COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY Nov 18, 2019 Abandoned
Array ( [id] => 19608875 [patent_doc_number] => 12157741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Macrocyclic inhibitors of DYRK1A [patent_app_type] => utility [patent_app_number] => 17/293292 [patent_app_country] => US [patent_app_date] => 2019-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25726 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 306 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293292 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/293292
Macrocyclic inhibitors of DYRK1A Nov 18, 2019 Issued
Array ( [id] => 17561640 [patent_doc_number] => 20220125789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => PHARMACEUTICAL PREPARATION OF FRUQUINTINIB AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/293790 [patent_app_country] => US [patent_app_date] => 2019-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3054 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293790 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/293790
PHARMACEUTICAL PREPARATION OF FRUQUINTINIB AND USE THEREOF Nov 14, 2019 Pending
Array ( [id] => 17342088 [patent_doc_number] => 20220008419 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING DIFFUSE-TYPE GASTRIC CANCER [patent_app_type] => utility [patent_app_number] => 17/293114 [patent_app_country] => US [patent_app_date] => 2019-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9317 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293114 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/293114
PHARMACEUTICAL COMPOSITION FOR TREATING DIFFUSE-TYPE GASTRIC CANCER Nov 13, 2019 Abandoned
Array ( [id] => 17342061 [patent_doc_number] => 20220008392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => METHODS OF TREATING CANCER [patent_app_type] => utility [patent_app_number] => 17/293155 [patent_app_country] => US [patent_app_date] => 2019-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293155 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/293155
METHODS OF TREATING CANCER Nov 12, 2019 Abandoned
Array ( [id] => 17368111 [patent_doc_number] => 20220023163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => COMPOSITION COMPRISING TWO POLYGLYCERYL FATTY ACID ESTERS [patent_app_type] => utility [patent_app_number] => 17/296955 [patent_app_country] => US [patent_app_date] => 2019-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8733 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296955 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/296955
COMPOSITION COMPRISING TWO POLYGLYCERYL FATTY ACID ESTERS Nov 5, 2019 Pending
Array ( [id] => 17334702 [patent_doc_number] => 20220001033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS [patent_app_type] => utility [patent_app_number] => 17/290727 [patent_app_country] => US [patent_app_date] => 2019-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19213 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290727 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/290727
PHOSPHATE COMPOUNDS FOR DETECTING NEUROLOGICAL DISORDERS Oct 31, 2019 Abandoned
Array ( [id] => 17212985 [patent_doc_number] => 20210346321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => PHARMACEUTICAL COMPOSITION CONTAINING ALKYL CARBAMOYL NAPHTHALENYLOXY OCTENOYL HYDROXYAMIDE PHOSPHATE, TARTRATE OR COMBINATION THEREOF, AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 17/283627 [patent_app_country] => US [patent_app_date] => 2019-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283627 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/283627
PHARMACEUTICAL COMPOSITION CONTAINING ALKYL CARBAMOYL NAPHTHALENYLOXY OCTENOYL HYDROXYAMIDE PHOSPHATE, TARTRATE OR COMBINATION THEREOF, AND PREPARATION METHOD THEREFOR Oct 27, 2019 Pending
Array ( [id] => 17290806 [patent_doc_number] => 20210386645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => TOPICAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/283111 [patent_app_country] => US [patent_app_date] => 2019-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3757 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283111 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/283111
TOPICAL COMPOSITIONS Oct 3, 2019 Abandoned
Menu